Price$12.12-0.15 (-1.22%)
04:00 PM07:45 PM
News · 26 weeks45-29%
2026-03-082026-08-30
Mix1590d
- Other5(33%)
- Insider4(27%)
- SEC Filings4(27%)
- Earnings2(13%)
Latest news
25 items- INSIDERDirector Kiai Parsa bought $529,157 worth of shares (43,150 units at $12.26) (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- PRMedifast® Announces the Launch of the Medifast Metabolic Health Institute™Backed by 45 years of Medifast clinical research, the institute elevates metabolic health as a cornerstone of well-being Medifast, Inc. (NYSE:MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education. The institute brings Medifast’s clinical research, scientific expertise, and educational resources under a single body, solidifying the company’s position in the metabolic health space. It follows the July launch of Trilivy™, which replaced OPTAVIA® as the company’s consumer brand and better reflects the company’s evolved focus on metabolic health. With metabolic dysfu
- INSIDERDirector Kiai Parsa bought $51,946 worth of shares (4,329 units at $12.00) (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Kiai Parsa bought $842,699 worth of shares (72,487 units at $11.63) (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by MEDIFAST INCSCHEDULE 13G/A - MEDIFAST INC (0000910329) (Subject)
- SECSEC Form S-8 filed by MEDIFAST INCS-8 - MEDIFAST INC (0000910329) (Filer)
- SECSEC Form 10-Q filed by MEDIFAST INC10-Q - MEDIFAST INC (0000910329) (Filer)
- SECMEDIFAST INC filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MEDIFAST INC (0000910329) (Filer)
- PRMedifast Announces Second Quarter 2026 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, today reported results for the second quarter ended June 30, 2026. Second Quarter 2026 Revenue: $76.4 million, with revenue per active earning coach of $6,529 Independent active earning coaches of 11,700 Net loss of $3.1 million or $0.28 loss per diluted share ("EPS") Cash, Cash Equivalents, and Investment Securities of $169.8 million with no debt Nick Johnson, Chief Executive Officer, commented, "In the second quarter, we continued to see signs of a turnaround in our business. Revenue remained sequentially stable, supported by steady growth in c
- PRMedifast to Announce Financial Results for the Second Quarter Ended June 30, 2026Medifast (NYSE:MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended June 30, 2026 on Monday, August 3, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 3, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at ht
- SECMEDIFAST INC filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - MEDIFAST INC (0000910329) (Filer)
- PRMedifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health SystemThe leading health and wellness company unveils an evolutionary transformation from weight loss to optimal metabolic health, powered by breakthrough science and human connection Medifast, Inc. (NYSE:MED) today announced the launch of Trilivy, a comprehensive metabolic health system uniquely designed to support healthy lifestyle change. The launch also introduces newly formulated meal replacements, including the Trilivy Reset Fueling line enhanced with MetaVantage Technology™, a platform of proprietary ingredient formulas intended to optimize metabolism by unlocking key metabolic pathways. The launch of Trilivy marks a major corporate transformation, and the beginning of a new era focused
- INSIDERAmendment: New insider Kiai Parsa claimed ownership of 607,796 shares (SEC Form 3)3/A - MEDIFAST INC (0000910329) (Issuer)
- PRWhat Science-Backed Subscription Health Programs Measure DifferentlyThe weight loss and weight management market was valued at $31.07 billion in 2025 A program can describe its results as clinically meaningful without specifying what was measured, how it was measured, or whether the measurement tool was capable of capturing the outcome being claimedDXA scanning distinguishes fat mass, lean mass, and bone mineral content with greater precision than BMI calculations and just weight number on a scaleStudy completion rates carry significant weight in how research findings should be interpreted BALTIMORE, MD, June 11, 2026 (GLOBE NEWSWIRE) -- Subscription health programs compete on outcome language as much as they compete on results. Terms like "clinically st
- PRMetabolic Health After 40: What Perimenopause and Menopause Mean for Weight ManagementDeclining estrogen during perimenopause accelerates visceral fat accumulation and lean muscle loss, two outcomes that standard weight management programs are not designed to address together (Szeliga A, et al., 2026)Women in midlife who focus on scale weight alone may be measuring the wrong thing: visceral fat and lean mass retention are the markers that reflect metabolic progressSleep disruption, elevated stress, and hormonal variability during midlife create conditions where self-directed programs stallThe coaching gap in weight loss outcomes becomes more significant during hormonal transition, when behavioral disruptions make self-directed programs harder to sustain BALTIMORE, MD, June
- SECMEDIFAST INC filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MEDIFAST INC (0000910329) (Filer)
- INSIDERDirector Rose Jeffrey Matthew was granted 18,419 shares (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Kiai Parsa was granted 19,317 shares (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Thomas Andrea B was granted 11,680 shares, increasing direct ownership by 49% to 35,697 units (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Schlackman Scott was granted 11,680 shares, increasing direct ownership by 38% to 42,229 units (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Geary Elizabeth A. was granted 11,680 shares, increasing direct ownership by 60% to 31,225 units (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERSEC Form 4 filed by Director Xian Ming4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERSEC Form 3 filed by new insider Rose Jeffrey Matthew3 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERNew insider Kiai Parsa claimed ownership of 657,590 shares (SEC Form 3)3 - MEDIFAST INC (0000910329) (Issuer)
- SECMEDIFAST INC filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MEDIFAST INC (0000910329) (Filer)
MED FAQ
6 questionsWhat does MEDIFAST INC do?
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale transactions over ecommerce platform and...Where does MED stock trade?
MEDIFAST INC (MED) is listed on NYSE.What sector and industry is MED in?
MEDIFAST INC operates in the Consumer Staples sector, Packaged Foods industry.What are analysts saying about MED?
MEDIFAST INC has had 7 recent analyst actions on file. The most recent action was from DA Davidson: Neutral with a $1700.00 price target on 2024-11-05. Recent price targets range from $1700.00 to $1750.00.What companies are similar to MED?
Notable peers in the same industry include MDLZ (Mondelez International Inc.), ADM (Archer-Daniels-Midland Company), KHC (The Kraft Heinz Company), BG (Bunge Limited), K (Kellanova). Compare MED side-by-side with any of them on Quantisnow.How can I track MED on Quantisnow?
Quantisnow aggregates MEDIFAST INC's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MED to receive live email and push alerts on every new disclosure.